Business UpdateJun 12, 2026, 10:01 AM
MindWalk CEO to Join Jones AI Day Panel on AI Drug Discovery
AI Summary
MindWalk Holdings Corp. announced that its President and CEO, Dr. Jennifer Bath, will participate in a virtual panel at Jones AI Day on June 15, 2026. The panel, titled "Partnering to Power the New Era of Drug Discovery," will explore how advanced computing and AI can overcome challenges in drug discovery. Dr. Bath will discuss MindWalk's bio-native AI approach, emphasizing its HYFT® technology and ReefIQ™ biological context layer, which features 660 million biological patterns and 25 billion relationships, and the LensAI™ platform, which is already in contracted arrangements with customers.
Key Highlights
- MindWalk CEO Dr. Jennifer Bath to join Jones AI Day panel on June 15, 2026.
- Panel to discuss AI drug discovery with Absci and a leading AI compute provider.
- MindWalk's HYFT® technology powers ReefIQ™, a biological context layer.
- ReefIQ™ contains 660 million biological patterns and 25 billion relationships.
- LensAI™ platform serves as the reasoning layer, with contracted customer arrangements.
- MindWalk's AI architecture designed to prevent hallucination in drug discovery.
Price Impact
More from HYFT